Cargando…

Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer

PURPOSE: We aimed to investigate the role of dual-phase FDG PET/CT in predicting the prognosis of patients with operable breast cancer. METHODS: We retrospectively reviewed the data of 998 patients who underwent radical treatment for breast cancer. Before treatment, PET/CT scans were performed 1 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikejiri, Haruka, Sasada, Shinsuke, Emi, Akiko, Masumoto, Norio, Kadoya, Takayuki, Okada, Morihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344020/ https://www.ncbi.nlm.nih.gov/pubmed/35921799 http://dx.doi.org/10.1016/j.breast.2022.07.008

Ejemplares similares

Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography
por: Sasada, Shinsuke, et al.
Publicado: (2022)

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer
por: Aogi, Kenjiro, et al.
Publicado: (2015)

Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study
por: Sasada, Shinsuke, et al.
Publicado: (2020)

Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
por: Amioka, Ai, et al.
Publicado: (2021)

Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study
por: Kadoya, Takayuki, et al.
Publicado: (2013)

The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
por: Goda, Noriko, et al.
Publicado: (2022)

Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer
por: Kobayashi, Yoshie, et al.
Publicado: (2018)

A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2011)

Application of PET/CT to adjuvant chemotherapy for early lung adenocarcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2015)

Detectability of Breast Tumor by a Hand-held Impulse-Radar Detector: Performance Evaluation and Pilot Clinical Study
por: Song, Hang, et al.
Publicado: (2017)

Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles
por: Koi, Yumiko, et al.
Publicado: (2020)

Diagnostic performance of peripheral leukocyte telomere G‐tail length for detecting breast cancer
por: Koi, Yumiko, et al.
Publicado: (2020)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

Role of FDG-PET/CT in prediction of pathological tumor response and survival after trimodality therapy for esophageal squamous cell carcinoma
por: Hamai, Yoichi, et al.
Publicado: (2015)

Improved diagnosis of pelvic lesions with dual-phase (18F)FDG-PET/CT
por: Pelosi, Ettore, et al.
Publicado: (2015)

A potential diagnostic role of dual-phase 18F-FDG PET/CT scanning
por: Jones, Clare, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Dual time point imaging of FDG PET/CT in a tuberculous spondylodiscitis
por: Abdul, HR, et al.
Publicado: (2010)

Implication of FDG-PET/CT in patients with potentially operable colorectal lung metastases
por: Uporov, Anton, et al.
Publicado: (2021)

Comparison of (18)F-FDG PET/CT imaging with different dual time (18)F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer
por: Yu, Longhua, et al.
Publicado: (2023)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis
por: Scholtens, A. M., et al.
Publicado: (2017)

Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT
por: Okada, Tomohisa, et al.
Publicado: (2022)

FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
por: Hannequin, Pascal, et al.
Publicado: (2022)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis
por: Gormsen, Lars C., et al.
Publicado: (2016)

Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
por: Emsen, Berivan, et al.
Publicado: (2020)

Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
por: Tsutani, Yasuhiro, et al.
Publicado: (2015)

Riedel’s Thyroiditis with Intense FDG Uptake Demonstrated on FDG PET/CT
por: Mansberg, Robert, et al.
Publicado: (2015)

The role of FDG-PET/CT in gynaecological cancers
por: Rockall, Andrea G, et al.
Publicado: (2012)

Lymphomatoid Granulomatosis: CT and FDG-PET Findings
por: Chung, Jonathan H., et al.
Publicado: (2011)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

The Importance of FDG-PET/CT in Cogan’s Syndrome
por: Örsal, Ebru, et al.
Publicado: (2014)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

Usefulness of FDG PET/CT in the management of tuberculosis
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2019)

Role of FDG PET/CT in Baastrup's disease
por: Subramanyam, Padma, et al.
Publicado: (2016)

FDG PET/CT Findings in Biliary Papillomatosis
por: Tu, Zhuolong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eulpaejhhe9p9asmarovpf7hd4